Microbiology

Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research

Retrieved on: 
Thursday, February 22, 2024
General Health, Health, Science, Pharmaceutical, Research, Bachelor of Science, Woman, Doctor of Philosophy, Seek, STEM, WITS, Inflammation, Drug discovery, Global health, University College Cork, Patient, Fibrosis, Knowledge, Microbiology, Recursion, Pharmaceutical industry

Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development.

Key Points: 
  • Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development.
  • With nearly 20 years of experience in R&D, phenotypic drug discovery, and assay and scientific operations, O’Mahony brings extensive knowledge and expertise to Seek Labs where she will spearhead the pharmaceutical research division, leading strategic initiatives to advance Seek Labs’ innovation in novel gene therapies.
  • "We are delighted to welcome Alison O’Mahony to Seek Labs as our new Vice President of Pharmaceutical Development," said Jared Bauer, CEO.
  • She also serves on professional boards including Talent Ready Utah, Breakthrough Cancer Research, and the Inflammation Research Association.

American Water Awarded New Research Grant Focusing on Early Warning System for Algal Blooms

Retrieved on: 
Wednesday, February 21, 2024
Natural Resources, Energy, Other Natural Resources, Other Energy, Utilities, American Water, WRF, Chemistry, City, Water, Microbiology, Spectral imaging, Drinking water, Role, Science, Research, Public, Medical device

American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., today announced that it has been awarded a new grant from The Water Research Foundation (WRF), Determining the Role of Spectral Imaging as an Early Warning System for Presence/Significance of Algal Blooms [5266].

Key Points: 
  • American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., today announced that it has been awarded a new grant from The Water Research Foundation (WRF), Determining the Role of Spectral Imaging as an Early Warning System for Presence/Significance of Algal Blooms [5266].
  • This research aims to develop cost-effective tools for early and reliable identification of harmful algal blooms.
  • “American Water is delighted to partner with The Water Research Foundation on this important water-related research, and continue to advance the science of drinking water,” said Lynda DiMenna, Chief Environmental Officer, American Water.
  • “Research into algal blooms is a critical component in continuing to provide clean, safe and reliable water services to customers and across the water industry.”
    Algal blooms can have negative impacts on both water providers and communities, affecting operations as well as public health.

NanoMosaic launches AAV gene therapy bioprocessing and manufacturing QC assays for simultaneous capsid & transgene interrogation with high standardization

Retrieved on: 
Wednesday, March 6, 2024
Doctor of Philosophy, University of Massachusetts, Capsid, Microbiology, Transgene, Genetic, GEN, Dicarboxylic acid, Data analysis, Protein, Patient safety, Heart, Mary Ann Liebert, QC, AAV, Research, SBS, Workflow, Vaccine

The assays are seamlessly deployable across upstream and downstream stages of the gene therapy workflow, while harmonizing the data from bioprocessing to batch release QC.

Key Points: 
  • The assays are seamlessly deployable across upstream and downstream stages of the gene therapy workflow, while harmonizing the data from bioprocessing to batch release QC.
  • "The objectives pursued by NanoMosaic are positive steps forward for a space desperate for a fit-for-purpose tool that can be standardized throughout the entire gene therapy development and manufacturing processes.
  • "NanoMosaic is excited to offer a unique solution to a challenging and fast-growing gene therapy market," said Qimin Quan, PhD, co-founder and Chief Scientific Officer.
  • NanoMosaic will feature the platform and unique gene therapy applications in a live broadcast scientific webinar alongside industry leaders on March 26, 2024, hosted by Genetic Engineering News (GEN).

SciBase Partners with Skinobs to Offer Nevisense on Global Cosmetic Testing Platform

Retrieved on: 
Wednesday, February 28, 2024
Health, Inflammation, Microbiology, Safety, Skin, Laboratory, Research, Nail, Partnership, Medical device

Through this partnership, SciBase will now offer Nevisense for assessing skin barrier function within cosmetic testing on the Skinobs platform.

Key Points: 
  • Through this partnership, SciBase will now offer Nevisense for assessing skin barrier function within cosmetic testing on the Skinobs platform.
  • Through the Skinobs platform, researchers can easily find information on who is conducting what tests in the field of dermocosmetic, nutraceutical, and active ingredient testing.
  • The cosmetic testing market segment represents a significant potential addressable customer base for SciBase and is expected to grow exponentially into 2030.
  • "SciBase is already involved in discussions with several large cosmetic companies who wish to use Nevisense in their research and development.

BayCare Names Three to Vice President Roles; Creates New Surgical Services Vice President Position

Retrieved on: 
Thursday, February 22, 2024
Acquisition, Hospital, Eckerd College, CPH, Pathology, Physician, Microbiology, University, Growth, Public health, Lynch, Central Florida, Diversity, Institutional review board, St. Petersburg College, Inclusion, Equity, Associate, MPH, Saint Leo University, Epidemiology, Research, Environment, Public, Nursing

The health system has also created a new vice president of perioperative services position to lead surgical services initiatives across BayCare's 16 hospitals.

Key Points: 
  • The health system has also created a new vice president of perioperative services position to lead surgical services initiatives across BayCare's 16 hospitals.
  • "It is my privilege to announce the naming of three long-time BayCare team members to vice president roles," said BayCare's Chief Team Resources Officer Kyle Barr.
  • Angel Brown has been promoted to vice president of talent acquisition and inclusion.
  • BayCare has announced plans to build a 17th hospital in Manatee County, where it already has doctor's offices, and it delivers home care services across 13 counties.

Town of Trenton fined $100,000 for violating the Fisheries Act in Nova Scotia

Retrieved on: 
Friday, February 16, 2024
Complaint, Speckled trout, Fishery, Town, Escherichia coli, Chemistry, Biophysical environment, Microbiology, Publishing, Registry, Sewage, Government, Climate change, Government of Canada, Fisheries Act, Safety, Trout, Atlantic salmon, Fund, NS, Direction, Environment, Water

On February 15, 2024, the Town of Trenton was ordered to pay a total of $100,000, after pleading guilty to one count of violating the Fisheries Act at the Provincial Court of Nova Scotia in Pictou County.

Key Points: 
  • On February 15, 2024, the Town of Trenton was ordered to pay a total of $100,000, after pleading guilty to one count of violating the Fisheries Act at the Provincial Court of Nova Scotia in Pictou County.
  • Some of the conditions include: training on the Fisheries Act and its requirements; training on proper effluent sampling protocols for Town of Trenton employees and contractors; completing routine sampling; and publishing emergency contact information and information about the incident and sentencing on the Town of Trenton website.
  • On November 13, 2019, Environment and Climate Change Canada enforcement officers received a complaint of a strong sewage smell around Lowden Brook along North Main Street in Trenton, Nova Scotia.
  • Environment and Climate Change Canada administers and enforces the pollution prevention provisions of the Fisheries Act.

Leading Intellectual Property Law Firm Fish & Richardson Launches Team Focused on Protecting Life Sciences Innovations

Retrieved on: 
Monday, February 12, 2024
Science, Legal, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Professional Services, Multimedia, Fish & Richardson, Microbiology, Risk, Doctor of Philosophy, Patent, IP, Senior counsel, Medtech, Pharmaceutical industry

Fish & Richardson has appointed leading trial attorney Martina Hufnal and veteran patent prosecutor Todd Garcia , Ph.D. to chair the firm’s Life Sciences Industry Team.

Key Points: 
  • Fish & Richardson has appointed leading trial attorney Martina Hufnal and veteran patent prosecutor Todd Garcia , Ph.D. to chair the firm’s Life Sciences Industry Team.
  • The team represents every sector of the life sciences market, including pharmaceutical, medical device, medtech and biotech companies, as well as academic and research institutions.
  • "Fish has a nationally recognized bench of trial attorneys and IP practitioners whose experience representing life sciences companies is second to none,” said Fish President and CEO John Adkisson .
  • Fish attorneys are experienced in each sector of the life sciences market, including small molecule, large molecule, medical device, medtech, and biotech.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX

Retrieved on: 
Sunday, February 11, 2024
Pomerantz, CRL, Chemistry, FDA, Prior, News, Food, Microbiology, Symantec Endpoint Protection, LLP, CMC

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Theratechnologies Inc. (“Theratechnologies” or the “Company”) (NASDAQ: THTX).

Key Points: 
  • NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Theratechnologies Inc. (“Theratechnologies” or the “Company”) (NASDAQ: THTX).
  • The investigation concerns whether Theratechnologies and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

NOW® Sports Named Official Sports Nutrition Partner of The Brooks Beasts Track Club

Retrieved on: 
Thursday, February 8, 2024
Collection, Beast, Sport, Microbiology, Partnership, Health, World championship, Sports Hub, Nutrition, Paris Olympics, Athlete, Science, NOW, Brooks Beasts Track Club

BLOOMINGDALE, Ill., Feb. 8, 2024 /PRNewswire/ -- NOW® Sports, the sports nutrition brand of industry-leading natural products manufacturer NOW®, is thrilled to announce its partnership with The Brooks Beasts Track Club as the Official Sports Nutrition Partner through 2024. The strategic alignment comes as Brooks professional athletes look to compete on the world's biggest stage at this summer's 2024 Paris Olympics and beyond and recognizes the importance of fueling with trusted and tested sports nutrition products to perform at the elite level.

Key Points: 
  • BLOOMINGDALE, Ill., Feb. 8, 2024 /PRNewswire/ -- NOW® Sports , the sports nutrition brand of industry-leading natural products manufacturer NOW®, is thrilled to announce its partnership with The Brooks Beasts Track Club as the Official Sports Nutrition Partner through 2024.
  • "We couldn't be more excited to partner with the Brooks Beasts," said Bryan Morin, NOW® Sports Brand Manager.
  • Nutrition plays a vital role in our success," said Danny Mackey, Brooks Beasts Head Coach.
  • NOW Sports products are available online at nowfoods.com , Amazon , or at fine health food stores and natural retailers nationwide.

As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in" Le microbiote français - Le French Gut "project to Propel Metagenomics Research

Retrieved on: 
Tuesday, February 6, 2024
Partnership, Metagenomics, Microbiology, Extrapyramidal system, Conditional sentence, Research, Patient, INRAE, Skin, Database, Food, MGI, Environment, Mouth

MetaGenoPolis will serve as a platform for processing samples from the project Le French Gut and for other researchers within the Million Microbiomes from Humans Project (MMHP).

Key Points: 
  • MetaGenoPolis will serve as a platform for processing samples from the project Le French Gut and for other researchers within the Million Microbiomes from Humans Project (MMHP).
  • "We are excited about the opportunity to further advance research in metagenomics sequencing," said Dr. Yong Hou, General Manager of MGI Europe and Africa.
  • The agreement underscores the commitment of both MGI and MetaGenoPolis to facilitate innovation in metagenomic research as part of MMHP and the project Le French Gut.
  • "We are delighted to partner with MGI to further our research objectives in MMHP and Le microbiote français - Le French Gut," said Alexandre Cavezza, Executive Director of MetaGenoPolis.